A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

Accepted

Journal Article

Full Text

Duke Authors

Cited Authors

  • Dummer, R; Daud, A; Puzanov, I; Hamid, O; Schadendorf, D; Robert, C; Schachter, J; Pavlick, A; Gonzalez, R; Hodi, FS; Cranmer, LD; Blank, C; O'Day, SJ; Ascierto, PA; Salama, AKS; Li, NX; Zhou, W; Lis, J; Ebbinghaus, S; Kang, PS; Ribas, A

Published Date

  • January 15, 2015

Published In

Start / End Page

  • 1 - 2

Electronic International Standard Serial Number (EISSN)

  • 1479-5876

Digital Object Identifier (DOI)

  • 10.1186/1479-5876-13-S1-O5

Citation Source

  • Scopus